SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-331168"
 

Search: onr:"swepub:oai:DiVA.org:kth-331168" > The humanised CYP2C...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

Milosavljević, Filip (author)
Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Brusini, Irene (author)
KTH,Medicinsk avbildning,Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden
Atanasov, Andrea (author)
Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
show more...
Manojlović, Marina (author)
Karolinska Institutet
Vučić, Marija (author)
Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Oreščanin-Dušić, Zorana (author)
Institute for Biological Research "Siniša Stanković" – National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
Brkljačić, Jelena (author)
Institute for Biological Research "Siniša Stanković" – National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
Miljević, Čedo (author)
Department of Psychiatry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Institute for Mental Health, Belgrade, Serbia
Nikolić-Kokić, Aleksandra (author)
Institute for Biological Research "Siniša Stanković" – National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
Blagojević, Duško (author)
Institute for Biological Research "Siniša Stanković" – National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
Wang, Chunliang, 1980- (author)
KTH,Medicinsk avbildning
Damberg, Peter (author)
Karolinska Experimental Research and Imaging Center, Karolinska University Hospital, Solna, Sweden
Pešić, Vesna (author)
Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Tyndale, Rachel F. (author)
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
Ingelman-Sundberg, Magnus (author)
Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Jukić, Marin M. (author)
Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
show less...
 (creator_code:org_t)
2023-01-17
2023
English.
In: Neuropathology and Applied Neurobiology. - : Wiley. - 0305-1846 .- 1365-2990. ; 49:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aims: CYP2C19 transgenic mouse expresses the human CYP2C19 gene in the liver and developing brain, and it exhibits altered neurodevelopment associated with impairments in emotionality and locomotion. Because the validation of new animal models is essential for the understanding of the aetiology and pathophysiology of movement disorders, the objective was to characterise motoric phenotype in CYP2C19 transgenic mice and to investigate its validity as a new animal model of ataxia. Methods: The rotarod, paw-print and beam-walking tests were utilised to characterise the motoric phenotype. The volumes of 20 brain regions in CYP2C19 transgenic and wild-type mice were quantified by 9.4T gadolinium-enhanced post-mortem structural neuroimaging. Antioxidative enzymatic activity was quantified biochemically. Dopaminergic alterations were characterised by chromatographic quantification of concentrations of dopamine and its metabolites and by subsequent immunohistochemical analyses. The beam-walking test was repeated after the treatment with dopamine receptor antagonists ecopipam and raclopride. Results: CYP2C19 transgenic mice exhibit abnormal, unilateral ataxia-like gait, clasping reflex and 5.6-fold more paw-slips in the beam-walking test; the motoric phenotype was more pronounced in youth. Transgenic mice exhibited a profound reduction of 12% in cerebellar volume and a moderate reduction of 4% in hippocampal volume; both regions exhibited an increased antioxidative enzyme activity. CYP2C19 mice were hyperdopaminergic; however, the motoric impairment was not ameliorated by dopamine receptor antagonists, and there was no alteration in the number of midbrain dopaminergic neurons in CYP2C19 mice. Conclusions: Humanised CYP2C19 transgenic mice exhibit altered gait and functional motoric impairments; this phenotype is likely caused by an aberrant cerebellar development.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Keyword

animal models
cerebellar ataxia
cerebellum
cytochrome P-450 Cyp2c19
movement disorders
neuroimaging
transgenic mice

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view